Skip to main content
. 2021 Aug 30;10(17):3904. doi: 10.3390/jcm10173904

Table 1.

Characteristics and pregnancy outcomes according to glycaemic status.

Available Data Total No HIP eGDM eDIP GDM DIP Global Comparison p-Value
n = 4665 n = 3563 n = 502 n = 26 n = 545 n = 29
Screening for HIP before 22 WG
Fasting plasma glucose (mmol/L) n = 4238 4.6 (0.6) 4.5 (0.3) 5.4 (0.4) ab 11.6 (3.4) a 4.6 (0.3) a 4.6 (0.3) <0.0001
Gestational age at HIP screening (WG) n = 4258 12.2 (4.2) 12.2 (4.2) 11.7 (4.5) 11.6 (0.7) 12.6 (4.1) 13.7 (4.5) 0.007
Screening with OGTT at 22 WG or later
Fasting plasma glucose (mmol/L) n = 3760 4.4 (0.5) 4.3 (0.4) - - 4.9 (0.6) a 5.3 (1.0) ac <0.0001
1-h plasma glucose (mmol/L) n = 3728 7.0 (1.8) 6.6 (1.5) - - 9.3 (1.7) a 11.0 (2.4) ac <0.0001
2-h plasma glucose (mmol/L) n = 3734 6.1 (1.5) 5.8 (1.1) - - 8.0 (1.6) a 11.6 (1.9) ac <0.0001
Gestational age at OGTT (WG) n = 4033 27.3 (3.0) 27.2 (3.0) - - 27.7 (3.3) a 27.6 (3.6) <0.0001
Metabolic characteristics
Age (years) n = 4665 30.7 (5.5) 30.2 (5.4) 32.6 (5.3) a 33.3 (5.4) a 32.1 (5.5) a 32.6 (5.2) <0.0001
Pre-pregnancy body mass index (kg/m2) n = 4515 25.2 (5.1) 24.7 (4.8) 28.0 (5.9) ab 27.7 (6.6) a 26.2 (5.4) a 27.7 (3.8) ac <0.0001
Pre-pregnancy obesity n = 4515 833 (18.5) 531 (15.4) 170 (34.9) ab 8 (32.0) 115 (21.9) a 9 (33.3) <0.0001
Pre-pregnancy hypertension n = 4665 39 (0.9) 20 (0.6) 9 (1.8) 1 (3.9) 9 (1.7) 0 (0) 0.0027
Family history of diabetes n = 4665 1291 (27.7) 892 (25.0) 204 (40.6) ab 12 (46.2) 175 (32.1) a 8 (27.6) <0.0001
Employment at beginning of pregnancy n = 4656 1887 (40.5) 1483 (41.7) 167 (33.3) a 9 (34.6) 217 (39.9) 11 (37.9) 0.0097
Parity n = 4665 2.1 (1.2) 2.1 (1.2) 2.3 (1.3) a 2.5 (1.7) 2.2 (1.3) 1.8 (0.8) 0.0001
Previous pregnancy
History of HIP n = 4665 <0.0001 *
First child 1814 (38.9) 1452 (40.8) 147 (29.3) 7 (26.9) 195 (35.8) 13 (44.8)
No 2561 (54.9) 2005 (56.3) 260 (51.8) 10 (38.5) 273 (50.1) 13 (44.8)
Yes 290 (6.2) 106 (3.00) 95 (18.9) 9 (34.6) 77 (14.1) 3 (10.3)
History of large for gestational age infant n = 4665 <0.0001 *
First child 1814 (38.9) 1452 (40.8) 147 (29.3) 7 (26.9) 195 (35.8) 13 (44.8)
No 2688 (57.6) 2012 (56.5) 326 (64.9) 15 (57.7) 322 (59.1) 13 (44.8)
Yes 163 (3.5) 99 (2.8) 29 (5.8) a 4 (15.4) a 28 (5.1) a 3 (10.3)
History of hypertensive disorders n = 4665 0.0104 *
First pregnancy 1265 (27.1) 1018 (28.6) 96 (19.1) 6 (23.1) 139 (25.5) 6 (20.7)
No 3281 (70.3) 2462 (69.1) 383 (76.3) 18 (69.2) 395 (72.5) 23 (79.3)
Yes 119 (2.6) 83 (2.3) 23 (4.6) a 2 (7.7) 11 (2.0) 0 (0)
History of foetal death n = 4665 0.0418 *
First pregnancy 1265 (27.1) 1018 (28.6) 96 (19.1) 6 (23.1) 139 (25.5) 6 (20.7)
No 3307 (70.9) 2485 (69.7) 391 (77.9) 19 (73.1) 391 (71.7) 21 (72.4)
Yes 93 (2.0) 60 (1.7) 15 (3.0) 1 (3.9) 15 (2.8) 2 (6.9)
Smoking during pregnancy n = 4665 284 (6.1) 245 (6.9) 22 (4.4) 1 (3.9) 16 (2.9) a 0 (0) 0.0012
Ethnicity n = 4656 <0.0001
European 1269 (27.3) 1042 (29.3) 94 (18.8) 3 (11.5) 121 (22.2) 9 (31.0)
African 881 (18.9) 709 (19.9) 80 (16.0) 5 (19.2) 83 (15.3) 4 (13.8)
North African 1378 (29.6) 970 (27.3) 192 (38.3) 10 (38.5) 196 (36.0) 10 (34.5)
Asian 96 (2.1) 70 (2.00) 10 (2.00) 1 (3.9) 14 (2.6) 1 (3.5)
Caribbean 270 (5.8) 222 (6.2) 23 (4.6) 1 (3.9) 24 (4.4) 0 (0)
Indian-Pakistan-Sri Lankan 519 (11.2) 346 (9.7) 82 (16.4) 6 (23.1) 80 (14.7) 5 (17.2)
Other 243 (5.2) 197 (5.5) 20 (4.0) 0 (0) 26 (4.8) 0 (0)
Maternal outcomes
Gestational weight gain (kg) n = 4316 11.1 (5.5) 11.5 (5.5) 9.0 (5.4) ab 8.3 (4.7) a 10.4 (5.3) a 10.1 (5.0) <0.0001
Insulin therapy during pregnancy n = 1100 408 (37.1) - 231 (46.0) b 23 (88.5) 139 (25.5) 15 (51.7) c <0.0001
Caesarean section n = 4665 1038 (22.3) 750 (21.1) 139 (27.7) a 7 (26.9) 131 (24.0) 11 (37.9) 0.0019
Gestational hypertension n = 4665 126 (2.7) 87 (2.4) 26 (5.2) ab 2 (7.7) 8 (1.5) 3 (10.3) ac <0.0001
Preeclampsia n = 4665 90 (1.9) 66 (1.9) 9 (1.8) 1 (3.9) 11 (2.0) 3 (10.3) a 0.0211
Hypertensive disorders during pregnancy n = 4665 214 (4.6) 151 (4.2) 35 (7.0) a 3 (11.5) 19 (3.5) 6 (20.7) ac <0.0001
Neonatal outcomes
Birthweight (g) n = 4665 3294 (515) 3285 (508) 3335 (522) 3271 (573) 3321 (541) 3271 (643) 0.1984
Large-for-gestational-age infant n = 4665 468 (10.0) 325 (9.1) 60 (12.0) 4 (15.4) 76 (13.9) a 3 (10.3) 0.0039
Small-for-gestational-age infant n = 4665 448 (9.6) 347 (9.7) 48 (9.6) 1 (3.9) 48 (8.8) 4 (13.8) 0.7259
Gestational age at birth (weeks of gestation) n = 4665 39.7 (1.6) 39.7 (1.6) 39.5 (1.6) 38.7 (1.9) a 39.4 (1.6) a 39.0 (2.1) <0.0001
Preterm delivery (<37 weeks of gestation) n = 4665 259 (5.6) 173 (4.9) 38 (7.6) 4 (15.4) a 39 (7.2) 5 (17.2) 0.0002
Neonatal hypoglycaemia n = 4665 29 (0.6) 12 (0.3) 6 (1.2) a 0 (0) 8 (1.5) a 3 (10.3) a <0.0001
Neonatal death and stillbirth n = 4665 18 (0.4) 14 (0.4) 2 (0.4) 0 (0) 2 (0.4) 0 (0) 0.0669
Malformation n = 4665 51 (1.1) 32 (1.0) 11 (2.2) a 2 (7.7) a 6 (1.1) 0 (0) 0.0014

Data are n (%) or mean (standard deviation). DIP—late-diagnosed (i.e., ≥22 weeks of gestation) diabetes in pregnancy; eDIP—early-diagnosed (i.e., <22 weeks of gestation) diabetes in pregnancy; eGDM—early-diagnosed gestational diabetes mellitus; GDM—late-diagnosed gestational diabetes mellitus; HIP—hyperglycaemia in pregnancy. a Significant difference after Bonferroni correction for the comparison of each group of HIP with no-HIP. b Significant difference after Bonferroni correction for the comparison between eGDM and GDM. c Significant difference after Bonferroni correction for the comparison between DIP and GDM. * “Yes” versus “No” or “First child”.